ScanSource (SCSC) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
25 Aug, 2026Executive summary
Achieved strong Q4 and full-year results, with Q4 net sales up 17.3% year-over-year and full-year net sales up 6.1%, reflecting disciplined execution and improved demand across all business segments.
Announced a definitive agreement to acquire MicroAge, a leading IT solutions integrator, for $220.5 million in cash, expanding TAM, services, and end-user visibility in high-growth areas like cloud, cybersecurity, data center, and AI.
Leadership changes and renewed focus on market share gains contributed to broad-based demand and improved performance.
Financial highlights
Q4 net sales: $953.1M (+17.3% YoY); full-year net sales: $3.23B (+6.1% YoY); Q4 gross profit: $119.8M (+14.0% YoY); gross margin 12.6%.
Q4 GAAP net income: $25.6M (+27.5% YoY); diluted EPS: $1.24 (+40.9% YoY); Q4 non-GAAP EPS: $1.46 (+43% YoY, company record).
Full-year GAAP net income: $78.9M (+10.2% YoY); diluted EPS: $3.64 (+21.3% YoY); adjusted EBITDA Q4: $46.1M (+19.4% YoY); full-year: $151.5M (+4.8% YoY).
Free cash flow for FY26: $113.8M; annual free cash flow reached $114 million, with a 124% conversion of non-GAAP net income.
Recurring revenues up 10.6% year-over-year, contributing 34% of gross profit.
Outlook and guidance
FY27 organic revenue expected to grow 6%-10%, excluding MicroAge acquisition benefits.
Adjusted EBITDA projected between $158 million and $165 million, with a margin of 4.6%-4.84%.
Free cash flow guidance set at a minimum of $85 million; effective tax rate expected between 27.5%-28.5%.
Stronger percentage growth anticipated in the first half of FY27 due to easier comps.
Latest events from ScanSource
- Recurring revenue and strategic M&A drive margin expansion and sustainable growth.SCSC
Investor presentation - Recurring revenue and margin expansion drive growth, supported by disciplined capital allocation.SCSC
Investor presentation - Quarterly sales up 8.8% to $766.8M, strong cash flow, margin gains, and new business initiatives.SCSC
Q3 2026 - Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference - Q2 FY26 saw 2.5% sales growth, margin pressure, and reduced full-year guidance.SCSC
Q2 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 2025 - Sales fell but margins and cash flow improved; acquisitions and hybrid strategy support growth.SCSC
Q4 2024 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 2025